StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > $1,65

<< Previous

Bullboard Posts

Next >>

Comment by Photoman77on Nov 12, 2021 10:15am

94 Views

Post# 34119318

RE:RE:RE:$1,65

I like to see both sides of the coin but i see where your going with this, all the bashers on ignore get noticed when you reply to their posts.

I will just post my own thread with my info to not give them any credit or relevance, even if i am replying to a bs comment they make, I will just make it my own point without reference. Gotcha

<< Previous

Bullboard Posts

Next >>

MDA Space stock blasts off on Q3 financial results